Equities

Pro-Dex Inc

Pro-Dex Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)27.18
  • Today's Change1.68 / 6.59%
  • Shares traded12.89k
  • 1 Year change+70.95%
  • Beta0.3576
Data delayed at least 15 minutes, as of Sep 19 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The one analyst offering a 12 month price target expects Pro-Dex Inc share price to rise to 30.00 in the next year from the last price of 27.62.
High8.6%30.00
Med8.6%30.00
Low8.6%30.00

Earnings history & estimates in USD

On Sep 05, 2024, Pro-Dex Inc reported 4th quarter 2024 earnings of 0.46 per share. This result exceeded the 0.35 expectation of the one analyst covering the company and exceeded last year's 4th quarter results by 9.52%.
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate+88.91%
Pro-Dex Inc reported annual 2024 earnings of 0.600 per share on Sep 05, 2024.
Average growth rate-3.11%
More ▼

Revenue history & estimates in USD

Pro-Dex, Inc. had 4th quarter 2024 revenues of 15.03m. This bettered the 10.60m estimate of the one analyst covering the company. This was 35.52% above the prior year's 4th quarter results.
Average growth rate+9.08%
Pro-Dex, Inc. had revenues for the full year 2024 of 53.84m. This was 16.83% above the prior year's results.
Average growth rate+11.54%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.